Osebold–Remondini syndrome

From WikiMD's Food, Medicine & Wellness Encyclopedia

Osebold–Remondini syndrome is a rare genetic disorder characterized by multiple congenital anomalies. The syndrome was first described by American geneticist William R. Osebold and Italian geneticist Giuseppe Remondini in 1981.

Clinical Features[edit | edit source]

The clinical features of Osebold–Remondini syndrome include craniofacial abnormalities, skeletal abnormalities, cardiac defects, and intellectual disability. The craniofacial abnormalities often include microcephaly (small head size), hypertelorism (widely spaced eyes), and cleft palate. Skeletal abnormalities may include scoliosis (curvature of the spine), pectus excavatum (sunken chest), and clubfoot. Cardiac defects can range from minor to severe, and may include congenital heart defects such as ventricular septal defect (hole in the heart). Intellectual disability is also common, with varying degrees of severity.

Genetics[edit | edit source]

Osebold–Remondini syndrome is thought to be an autosomal recessive disorder, which means that an individual must inherit two copies of the defective gene, one from each parent, in order to develop the syndrome. The exact gene responsible for the syndrome has not yet been identified.

Diagnosis and Treatment[edit | edit source]

Diagnosis of Osebold–Remondini syndrome is based on clinical features and may be confirmed by genetic testing. Treatment is symptomatic and supportive, and may include surgical correction of physical abnormalities, physical therapy, and special education services for intellectual disability.

See Also[edit | edit source]

References[edit | edit source]

Template:Genetic disorder

NIH genetic and rare disease info[edit source]

Osebold–Remondini syndrome is a rare disease.

Osebold–Remondini syndrome Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Admin, Prab R. Tumpati, MD